Viewing Study NCT03526250


Ignite Creation Date: 2025-12-24 @ 5:02 PM
Ignite Modification Date: 2026-01-24 @ 6:58 PM
Study NCT ID: NCT03526250
Status: COMPLETED
Last Update Posted: 2024-11-01
First Post: 2018-05-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Recurrent Childhood Ependymoma View
None Recurrent Ewing Sarcoma View
None Recurrent Glioma View
None Recurrent Hepatoblastoma View
None Recurrent Kidney Wilms Tumor View
None Recurrent Langerhans Cell Histiocytosis View
None Recurrent Malignant Germ Cell Tumor View
None Recurrent Malignant Glioma View
None Recurrent Medulloblastoma View
None Recurrent Neuroblastoma View
None Recurrent Non-Hodgkin Lymphoma View
None Recurrent Osteosarcoma View
None Recurrent Peripheral Primitive Neuroectodermal Tumor View
None Recurrent Rhabdoid Tumor View
None Recurrent Rhabdomyosarcoma View
None Recurrent Soft Tissue Sarcoma View
None Refractory Ependymoma View
None Refractory Ewing Sarcoma View
None Refractory Glioma View
None Refractory Hepatoblastoma View
None Refractory Langerhans Cell Histiocytosis View
None Refractory Malignant Germ Cell Tumor View
None Refractory Malignant Glioma View
None Refractory Medulloblastoma View
None Refractory Neuroblastoma View
None Refractory Non-Hodgkin Lymphoma View
None Refractory Osteosarcoma View
None Refractory Peripheral Primitive Neuroectodermal Tumor View
None Refractory Rhabdoid Tumor View
None Refractory Rhabdomyosarcoma View
None Refractory Soft Tissue Sarcoma View
Keywords: